Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000298412, "novel transcript, sense intronic to CAST," refers to a predicted or newly discovered lncRNA located within an intron of the calpastatin (CAST) gene, expressed on the sense strand. Such transcripts are commonly found in high-throughput transcriptomic studies and may be byproducts of transcriptional activity or may have regulatory functions, but there is no evidence this transcript encodes a protein or acts as a functional therapeutic target. It is not recognized as a receptor, enzyme, transporter, or transcription factor, and its biological role, if any, is currently unknown. This entry should not be considered a conventional drug target in pharmacology or biomedicine. Summary of quality and limitations: - This target is not a conventional drug target. - It lacks functional, clinical, or pharmacological characterization. - It may be an annotation artifact or a byproduct of expanding transcriptomic catalogues. If you require a canonical, well-validated target for therapeutic research, this entry would not be considered appropriate.
None known (not a druggable target, enzyme, or receptor; uncharacterized).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to calpastatin (ENSG00000298412).